Biomedical Research
Conditions
Keywords
Patient willingness, Participation
Brief summary
The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project.
Detailed description
Over time, clinical research has become a challenge both in terms of public health and in terms of scientific progress. Additionally, it has also become a financial challenge for institutions, especially in France where a significant part of their government funding is provided according to their ability to conduct quality clinical research. Pulmonology is a sector where clinical research is well established with strong incentives from several pharmaceutical companies and numerous academic research projects. Nevertheless, it is important to put the patient back at the centre of biomedical research. A better knowledge of patient expectations, questions and misunderstandings would considerably improve treatment observance, clinical trial data quality, doctor-patient trust/relationship, and ultimately, the patient's health. The primary objective of this study is to determine how biomedical research is perceived by patients already participating in a pulmonology research project. The secondary objectives are to determine: * how biomedical research is experienced / felt; * if the information delivered to the patient (orally - information note) is clearly perceived. Comparisons with PROTOACCEPT1 (osf.io/nsjjr) will also be performed.
Interventions
OTHERQuestionnaire
The Questionnaire is provided in the links at the end of the declaration.
Sponsors
University Hospital, Montpellier
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* The patient presents with at least one of the following: (1) asthma, (2) chronic obstructive pulmonary disease, (3) bronchiectasis, (4) idiopathic pulmonary fibrosis, (5) pulmonary arterial hypertension, (6) sleep apnoea syndrome * The patient is participating in a biomedical research protocol.
Exclusion criteria
* Patient under 18 years of age * Patient judged incapable of filling out the questionnaire for linguistic or other reasons. * The patient has already participated in the present study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The PROTOACCEPT2 questionnaire. | day 0 (transversal study) |
Countries
France
Outcome results
None listed